These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 9501

  • 21. Studies on positive inotropic agents. IV. Synthesis of 5-(3-amino-2-hydroxypropoxy)-3,4-dihydro-8-hydroxy-2(1H)-quinolinone derivatives.
    Tominaga M, Ogawa H, Yo E, Yamashita S, Yabuuchi Y, Nakagawa K.
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3699-704. PubMed ID: 3435968
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Synthesis of a novel series of (aryloxy)propanolamines: new selective beta 2-blocking agents.
    Carre MC, Youlassani A, Caubere P, Saint-Aubin-Floch A, Blanc M, Advenier C.
    J Med Chem; 1984 Jun; 27(6):792-9. PubMed ID: 6145801
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. 2-(Isoxazolylethenyl)phenoxypropanolamines: a new class of beta-receptor antagonists with antihypertensive activity.
    Franke A, Frickel FF, Gries J, Lenke D, Schlecker R, Thieme PD.
    J Med Chem; 1981 Dec; 24(12):1460-4. PubMed ID: 6118439
    [Abstract] [Full Text] [Related]

  • 27. beta-adrenergic blocking agents. 24. Heterocyclic substituted 1-(aryloxy)-3-[[(amido)alkyl]amino]propan-2-ols.
    Large MS, Smith LH.
    J Med Chem; 1982 Dec; 25(12):1417-22. PubMed ID: 6130155
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. beta 1-selective adrenoceptor antagonists. 1. Synthesis and beta-adrenergic blocking activity of a series of binary (aryloxy)propanolamines.
    Kierstead RW, Faraone A, Mennona F, Mullin J, Guthrie RW, Crowley H, Simko B, Blaber LC.
    J Med Chem; 1983 Nov; 26(11):1561-9. PubMed ID: 6138434
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [3-(3-Isopropylamino-2-hydroxypropoxy)estra-1,3,5(10)-trien-17-one].
    Da Re P, Valenti P, Braga PC, Ferri S.
    Arch Pharm (Weinheim); 1975 Dec; 308(12):981-2. PubMed ID: 4050
    [No Abstract] [Full Text] [Related]

  • 37. [(Arylcarbonyl)oxy]propanolamines. 1. Novel beta-blockers with ultrashort duration of action.
    Kam ST, Matier WL, Mai KX, Barcelon-Yang C, Borgman RJ, O'Donnell JP, Stampfli HF, Sum CY, Anderson WG, Gorczynski RJ.
    J Med Chem; 1984 Aug; 27(8):1007-16. PubMed ID: 6146718
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Selective beta 2-adrenoceptor antagonists: derivatives of ICI 118,551 and a binary aryloxypropanolamine.
    Nathanson JA, Hunnicutt EJ.
    J Pharm Pharmacol; 1988 Nov; 40(11):803-5. PubMed ID: 2907563
    [Abstract] [Full Text] [Related]

  • 40. An approach to peripheral vasodilator-beta-adrenergic blocking agents.
    Baldwin JJ, Hirschmann R, Lumma PK, Lumma WC, Ponticello GS, Sweet CS, Scriabine A.
    J Med Chem; 1977 Aug; 20(8):1024-9. PubMed ID: 19628
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.